iMD Companies, Inc. (OTC: ICBU) announced today that it has entered into advanced due diligence on two potential acquisition targets, one in the cryptocurrency infrastructure sector and the other in the medical technology space. The company, which focuses on acquisitions and technology in crypto, blockchain, and application development, believes these opportunities align with its strategic focus on high-growth industries supported by scalable technologies and long-term market demand.
According to the press release, the due diligence process is ongoing, with completion anticipated in the coming weeks. iMD Companies will provide updates as appropriate as evaluations progress. The company emphasized its commitment to maintaining transparency with shareholders and communicating material developments in a timely manner.
“We are encouraged by the progress we’ve made in evaluating these opportunities,” said Richard Wilson, CEO of iMD Companies, Inc. “Our approach remains disciplined and focused on identifying assets that can deliver sustainable growth and long-term value for our shareholders.”
The announcement comes as iMD Companies continues to pursue growth through strategic acquisitions. The company, based in Rancho Cordova, CA, is publicly traded on the OTC Markets under the symbol ICBU. More information about iMD Companies can be found at imdcompaniesinc.com or on OTC Markets. For real-time updates, the company encourages following @imd_inc on X.
This development is important for investors and industry observers as it signals iMD Companies’ intent to expand its footprint in both the cryptocurrency and medical technology sectors. The cryptocurrency infrastructure sector has seen increased interest as digital assets gain mainstream adoption, while medical technology continues to be a growth area driven by innovation and aging populations. Successful acquisitions could position iMD Companies to capitalize on these trends and potentially enhance shareholder value.
However, the company cautioned that forward-looking statements in the release involve risks and uncertainties. Factors such as market conditions, regulatory changes, and the outcome of due diligence could affect the finalization of any acquisitions. iMD Companies stated it does not undertake any obligation to update forward-looking statements except as required by law.
The due diligence process is a critical step before any acquisition, involving thorough evaluation of financials, operations, and strategic fit. As iMD Companies progresses, market participants will be watching for further details on the targets and the potential impact on the company’s growth trajectory.
